Samjin anti-viral drug appointed to NIH/NIAID project.

An anti-viral compound, a pyrimidindione derivative, developed by Samjin has been appointed as one of the topical anti-viral drug R&D projects for the prevention of HIV infections by the U. S. NIH (NIH/NIAID).

It is effective against HIV-1 and HIV-2 virus, showing quite a high level (at 500 thousand to 4 million) of therapeutic index on a duplicated mode of actions (inhibition to the reverse...